THE CLINICAL EFFECTS OF THE CONTINUOUS INTRAVENOUS INFUSION OF CANCER CHEMOTHERAPEUTIC COMPOUNDS.
D000900:Anti-Bacterial Agents; D000904:Antibiotics, Antitubercular; D000970:Antineoplastic Agents; D005467:Floxuridine; D005472:Fluorouracil; D007262:Infusions, Intravenous; D007263:Infusions, Parenteral; D008727:Methotrexate; D016685:Mitomycin; D008937:Mitomycins; D009369:Neoplasms; D013936:Thymidine
D000900:Anti-Bacterial Agents; D000904:Antibiotics, Antitubercular; D000970:Antineoplastic Agents; D008937:Mitomycins; D005467:Floxuridine; D016685:Mitomycin; D005472:Fluorouracil; D013936:Thymidine; D008727:Methotrexate
ANTIBIOTICS; ANTINEOPLASTIC AGENTS; FLUORODEOXYURIDINE; FLUOROURACIL; INFUSIONS, PARENTERAL; METHOTREXATE; MITOMYCIN; THYMIDINE